The Centers for Medicare and Medicaid Services is drawing fire for refusing to cover immunotherapy drugs that target early-stage Alzheimer s disease, although the United States Food and Drug Administration has approved them.
Joe Arciniega is leading another rally in Dallas on Tuesday as the Alzheimer s Association and AIM continue seeking Medicare and Medicaid approval from the CMS.
The FDA approved immunotherapy drugs that target early-stage Alzheimer’s disease. The Centers for Medicare and Medicaid Services is drawing fire for refusing to cover the monoclonal antibody treatment.
The Centers for Medicare and Medicaid Services is drawing fire for refusing to cover immunotherapy drugs that target early-stage Alzheimer s disease, although the United States Food and Drug Administration has approved them.